2025 USP Convention Meeting – Cate Lockhart wants more quality-assured biosimilars

2025 USP Convention Meeting – Cate Lockhart wants more quality-assured biosimilars

Cate Lockhart, PharmD, PhD, is Chief Science Officer at the Academy of Managed Care Pharmacy, a USP Convention Member Organization. She explains how supply chains for biosimilar medicines present unique challenges and opportunities. Learn more about the USP Convention: https://www.usp.org/about/usp-convention #USPConventionMeeting2025 #ProudtobeUSP